California State Teachers Retirement System (CalSTRS)
CLDX icon

California State Teachers Retirement System (CalSTRS)’s Celldex Therapeutics CLDX Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89M Sell
77,723
-1,907
-2% -$61.6K ﹤0.01% 1419
2026
Q1 		$2.53M Buy
79,630
+21,233
+36% +$579K ﹤0.01% 1393
2025
Q4 		$1.59M Buy
58,397
+2,886
+5% +$76K ﹤0.01% 1547
2025
Q3 		$1.44M Buy
55,511
+3
+0% +$70 ﹤0.01% 1597
2025
Q2 		$1.13M Sell
55,508
-662
-1% -$12.9K ﹤0.01% 1666
2025
Q1 		$1.02M Hold
56,170
– – ﹤0.01% 1690
2024
Q4 		$1.42M Sell
56,170
-327
-0.6% -$8.88K ﹤0.01% 1584
2024
Q3 		$1.92M Sell
56,497
-657
-1% -$25K ﹤0.01% 1432
2024
Q2 		$2.12M Sell
57,154
-1,249
-2% -$47.1K ﹤0.01% 1344
2024
Q1 		$2.45M Buy
58,403
+6,929
+13% +$285K ﹤0.01% 1289
2023
Q4 		$2.04M Buy
51,474
+5,721
+13% +$168K ﹤0.01% 1425
2023
Q3 		$1.26M Sell
45,753
-5,010
-10% -$157K ﹤0.01% 1656
2023
Q2 		$1.72M Buy
50,763
+611
+1% +$20.6K ﹤0.01% 1580
2023
Q1 		$1.8M Sell
50,152
-676
-1% -$29.2K ﹤0.01% 1548
2022
Q4 		$2.27M Buy
50,828
+545
+1% +$19.5K ﹤0.01% 1405
2022
Q3 		$1.41M Sell
50,283
-987
-2% -$30.3K ﹤0.01% 1669
2022
Q2 		$1.38M Sell
51,270
-187
-0.4% -$5.43K ﹤0.01% 1731
2022
Q1 		$1.75M Sell
51,457
-5,000
-9% -$160K ﹤0.01% 1712
2021
Q4 		$2.18M Sell
56,457
-226
-0.4% -$9.85K ﹤0.01% 1686
2021
Q3 		$3.06M Buy
56,683
+2,604
+5% +$122K ﹤0.01% 1448
2021
Q2 		$1.81M Buy
+54,079
New +$1.48M ﹤0.01% 1832
2018
Q2 		– Sell
-13,554
Closed -$474K – 3025
2018
Q1 		$474K Sell
13,554
-271
-2% -$10.5K ﹤0.01% 2390
2017
Q4 		$589K Buy
13,825
+960
+7% +$41.1K ﹤0.01% 2320
2017
Q3 		$552K Sell
12,865
-1,428
-10% -$53.5K ﹤0.01% 2366
2017
Q2 		$530K Buy
14,293
+1,746
+14% +$77.2K ﹤0.01% 2436
2017
Q1 		$679K Sell
12,547
-566
-4% -$29.5K ﹤0.01% 2309
2016
Q4 		$696K Sell
13,113
-374
-3% -$21.3K ﹤0.01% 2325
2016
Q3 		$817K Buy
13,487
+127
+1% +$7.91K ﹤0.01% 2203
2016
Q2 		$880K Sell
13,360
-550
-4% -$34.9K ﹤0.01% 2112
2016
Q1 		$789K Buy
13,910
+1,743
+14% +$196K ﹤0.01% 2153
2015
Q4 		$2.86M Buy
12,167
+196
+2% +$42.7K 0.01% 1317
2015
Q3 		$1.89M Sell
11,971
-20
-0.2% -$5.66K ﹤0.01% 1565
2015
Q2 		$4.54M Buy
11,991
+46
+0.4% +$18.3K 0.01% 1100
2015
Q1 		$4.99M Buy
11,945
+840
+8% +$300K 0.01% 1021
2014
Q4 		$3.04M Buy
11,105
+107
+1% +$26.6K 0.01% 1325
2014
Q3 		$2.14M Buy
10,998
+122
+1% +$26.6K 0.01% 1519
2014
Q2 		$2.66M Buy
10,876
+74
+0.7% +$16.7K 0.01% 1410
2014
Q1 		$2.86M Buy
10,802
+40
+0.4% +$15.3K 0.01% 1286
2013
Q4 		$3.91M Buy
10,762
+1,066
+11% +$411K 0.01% 1083
2013
Q3 		$5.15M Buy
9,696
+301
+3% +$103K 0.02% 883
2013
Q2 		$2.2M Buy
+9,395
New +$1.85M 0.01% 1326

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s CLDX Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Celldex Therapeutics (CLDX) stake by 2.4% in Q2 2026, selling an estimated $61.6K and leaving 77,723 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

California State Teachers Retirement System (CalSTRS) first reported a position in CLDX in Q2 2013 and has held it in 41 quarters since. The position peaked at $5.15M in Q3 2013. 253 funds tracked by Wall St. Rank hold CLDX as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 77,723 shares of Celldex Therapeutics worth $2.89M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 1,907 Celldex Therapeutics shares in Q2 2026, an estimated $61.6K.
  • Celldex Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1419 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Celldex Therapeutics in Q2 2013 and has held it in 41 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Celldex Therapeutics position peaked at $5.15M in Q3 2013.
  • 253 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.